chloroquine has been researched along with isoproterenol in 23 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 9 (39.13) | 18.7374 |
| 1990's | 4 (17.39) | 18.2507 |
| 2000's | 3 (13.04) | 29.6817 |
| 2010's | 6 (26.09) | 24.3611 |
| 2020's | 1 (4.35) | 2.80 |
| Authors | Studies |
|---|---|
| Topliss, JG; Yoshida, F | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Jones, LH; Nadanaciva, S; Rana, P; Will, Y | 1 |
| Amedome, A; Belghiti, D; Belghiti, J; Durand, H | 1 |
| Lockwood, TD; Thorne, DP | 1 |
| Okwuasaba, FK; Otubu, JA; Udoh, FV | 1 |
| Curtis, DH; Entwistle, A; Zalin, RJ | 1 |
| Eckel, J; Reinauer, H | 1 |
| Lockwood, TD | 1 |
| Mallory, P; Warhurst, DC | 1 |
| Hawkins, D | 1 |
| Furkert, K | 1 |
| Meier, KE; Ruoho, AE | 1 |
| Curran, PK; Fishman, PH; Orlandi, PA | 1 |
| Birnbaumer, L; Zhu, X | 1 |
| PETERS, W | 1 |
| Belvisi, MG; Birrell, MA; Canning, BJ; Dale, N | 1 |
| Ahn, K; An, SS; Koziol-White, CJ; Kurten, RC; Lee, DY; Liggett, SB; Panettieri, RA; Wang, WC | 1 |
| Agis-Torres, Á; Benedito, S; Climent, B; Fernandes, VS; Hernández, M; Hernández-Martín, M; López-Oliva, ME; Navarro-Dorado, J; Pilar Martínez, M; Recio, P; Victoria Barahona, M | 1 |
2 review(s) available for chloroquine and isoproterenol
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
[Antiasthmatics. 12].
Topics: Adrenal Cortex Hormones; Aminophylline; Anti-Bacterial Agents; Asthma; Atropine; Barbiturates; Bronchodilator Agents; Calcium Chloride; Central Nervous System Stimulants; Chloroquine; Ephedrine; Epinephrine; Expectorants; Histamine H1 Antagonists; Humans; Isoproterenol; Papaverine; Phenothiazines; Potassium Iodide; Theophylline; Trypsin | 1967 |
21 other study(ies) available for chloroquine and isoproterenol
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Development of a cell viability assay to assess drug metabolite structure-toxicity relationships.
Topics: Adenosine Triphosphate; Benzbromarone; Cell Line; Cell Survival; Chromans; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Humans; Pharmaceutical Preparations; Thiazolidinediones; Troglitazone | 2016 |
[Letter: Intoxication with chloroquine with cardiac disorders. Effect of isoprenaline].
Topics: Adolescent; Chloroquine; Heart Diseases; Humans; Hypotension; Isoproterenol; Male; Shock, Cardiogenic; Vision Disorders; Vomiting | 1975 |
Effects of insulin, biguanide antihyperglycaemic agents and beta-adrenergic agonists on pathways of myocardial proteolysis.
Topics: Adrenergic beta-Agonists; Animals; Biguanides; Chloroquine; Drug Therapy, Combination; In Vitro Techniques; Insulin; Isoproterenol; Lysosomes; Myocardial Contraction; Myocardium; Phenformin; Protease Inhibitors; Protein Denaturation; Rats | 1990 |
Mode of inhibitory actions of acute and chronic chloroquine administration on the electrically stimulated mouse diaphragm in vitro.
Topics: Animals; Caffeine; Calcium; Chloroquine; Dantrolene; Diaphragm; Electric Stimulation; Female; In Vitro Techniques; Isoproterenol; Male; Mice; Muscle Contraction; Muscle Relaxation; Muscle, Smooth; Potassium Chloride; Procaine; Thiocyanates; Tubocurarine | 1990 |
Myoblast fusion is regulated by a prostanoid of the one series independently of a rise in cyclic AMP.
Topics: Alprostadil; Animals; Arachidonic Acid; Arachidonic Acids; Cell Fusion; Cells, Cultured; Chick Embryo; Chloroquine; Cyclic AMP; Dinoprostone; Eicosanoic Acids; Indomethacin; Isoproterenol; Muscles; Propranolol; Prostaglandins E | 1986 |
Involvement of hormone processing in insulin-activated glucose transport by isolated cardiac myocytes.
Topics: 3-O-Methylglucose; Adenosine Triphosphate; Animals; Arsenicals; Biological Transport, Active; Cadaverine; Cell Separation; Chloroquine; Glucose; Heart; In Vitro Techniques; Insulin; Isoproterenol; Kinetics; Male; Methylglucosides; Myocardium; Rats; Rats, Inbred Strains | 1988 |
Distinction between major chloroquine-inhibitable and adrenergic-responsive pathways of protein degradation and their relation to tissue ATP content in the Langendorff isolated perfused rat heart.
Topics: 2,4-Dinitrophenol; Adenosine Triphosphate; Animals; Azides; Chloroquine; Dinitrophenols; Heart; Isoproterenol; Leucine; Lysosomes; Myocardium; Perfusion; Proteins; Rats; Sodium Azide | 1988 |
Observations on the binding site for antimalarial schizontocides.
Topics: Antimalarials; Binding Sites; Binding, Competitive; Chloroquine; Ephedrine; Isoproterenol; Plasmodium berghei; Quinine | 1973 |
Neutrophilic leukocytes in immunologic reactions in vitro. 3. Pharmacologic modulation of lysosomal constituent release.
Topics: Animals; Bucladesine; Chloroquine; Colchicine; Collagen; Epinephrine; Ethylmaleimide; Exocytosis; Ferritins; Glucose; Hydrocortisone; Iodoacetates; Isoproterenol; Latex; Lysosomes; Membranes; Microspheres; Models, Biological; Neutrophils; Phagocytosis; Phenylephrine; Propranolol; Rabbits; Salicylates; Theophylline; Vinblastine | 1974 |
Uptake of L-[propyl-2,3-3H]dihydroalprenolol by intact HeLa cells.
Topics: Adrenergic beta-Antagonists; Alprenolol; Binding, Competitive; Biological Transport; Cell Membrane; Chloroquine; Cold Temperature; Diffusion; Dihydroalprenolol; HeLa Cells; Humans; Hydrogen-Ion Concentration; Isoproterenol; Phentolamine; Pindolol; Receptors, Adrenergic, beta; Valinomycin | 1984 |
Brefeldin A blocks the response of cultured cells to cholera toxin. Implications for intracellular trafficking in toxin action.
Topics: Adenocarcinoma; Adenylyl Cyclases; Animals; Biological Transport; Brefeldin A; Cell Line; Chloroquine; Cholera Toxin; Colonic Neoplasms; Cyclic AMP; Cyclopentanes; Enzyme Activation; Glioma; Golgi Apparatus; Humans; Isoproterenol; Kinetics; Monensin; Mycotoxins; Rats; Time Factors; Tumor Cells, Cultured | 1993 |
G protein subunits and the stimulation of phospholipase C by Gs-and Gi-coupled receptors: Lack of receptor selectivity of Galpha(16) and evidence for a synergic interaction between Gbeta gamma and the alpha subunit of a receptor activated G protein.
Topics: Animals; Arginine Vasopressin; Carbachol; Cell Line; Chlorocebus aethiops; Chloroquine; Chorionic Gonadotropin; Enzyme Activation; GTP-Binding Proteins; Humans; Inositol Phosphates; Isoproterenol; Macromolecular Substances; Mice; Pertussis Toxin; Receptors, Adrenergic, beta; Receptors, LH; Receptors, Muscarinic; Receptors, Vasopressin; Recombinant Proteins; Transfection; Type C Phospholipases; Virulence Factors, Bordetella | 1996 |
PIGMENT FORMATION AND NUCLEAR DIVISION IN CHLOROQUINE-RESISTANT MALARIA PARASITES (PLASMODIUM BERGHEI, VINCKE AND LIPS, 1948).
Topics: Animals; Blood Pressure; Cats; Cell Nucleus Division; Chloroquine; Epinephrine; Isoproterenol; Lip; Malaria; Parasites; Pharmacology; Plasmodium berghei; Research; Sympatholytics | 1964 |
Bronchodilator activity of bitter tastants in human tissue.
Topics: Animals; Bronchi; Bronchodilator Agents; Chloroquine; Dose-Response Relationship, Drug; Guinea Pigs; Humans; Isoproterenol; Muscle Relaxation; Muscle, Smooth; Papaverine; Receptors, G-Protein-Coupled | 2011 |
TAS2R activation promotes airway smooth muscle relaxation despite β(2)-adrenergic receptor tachyphylaxis.
Topics: Adrenergic beta-Agonists; Albuterol; Animals; Chloroquine; Humans; In Vitro Techniques; Isoproterenol; Methacholine Chloride; Mice; Muscle Relaxation; Muscle, Smooth; Receptors, Adrenergic, beta-2; Receptors, G-Protein-Coupled; Respiratory Physiological Phenomena; Respiratory System; Tachyphylaxis | 2012 |
The bitter taste receptor (TAS2R) agonist denatonium promotes a strong relaxation of rat corpus cavernosum.
Topics: Animals; Chloroquine; Cyclic GMP; Isoproterenol; Male; Rats; Taste | 2023 |